obesity drug news today glp-1 october 27 2025 Alarming rise in weight loss overdoses Obesity GLP-1 Market Size to

Description

doi:10.1016/j.bcp.2019.03.024 Yang L, Yang J, Pan T, Zhong X

GLP-1s may be influencing breast cancer risk indirectly by improving some of the metabolic factors we know matter, including weight, insulin resistance, inflammation, and the hormonal environment, she told Healthline

This underscores the need for both RWE and RCTs in parallel and reinforces the need to need to run clinical trials that reflect real-world populations, a topic explored in more detail in our blog Obesity trials on trial Some health improvement seen with GLP-1 therapy may be a direct effect of weight loss, rather than unique drug effect as seen by improvements in liver and kidney health 4

Despite margin pressures, Hims noted that it has shipped more than 125,000 Wegovy shots and pills in just six weeks, and that its projected to add 100,000 new weight loss subscribers per month